Thalys Medical Technology Group Inc
SSE:603716
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Thalys Medical Technology Group Inc
SSE:603716
|
CN |
|
Hisar Metal Industries Ltd
NSE:HISARMETAL
|
IN |
|
Cathay Pacific Airways Ltd
HKEX:293
|
HK |
|
Lippo General Insurance Tbk PT
IDX:LPGI
|
ID |
|
L
|
Lagercrantz Group AB
LSE:0RB7
|
SE |
|
Airbus SE
PAR:AIR
|
NL |
|
Paysign Inc
NASDAQ:PAYS
|
US |
|
T
|
Toyota Motor Corp
LSE:TYT
|
JP |
Thalys Medical Technology Group Inc
Thalys Medical Technology Group, Inc. engages in the research, development, production, and sale of in vitro diagnostic products. The company is headquartered in Wuhan, Hubei and currently employs 1,637 full-time employees. The company went IPO on 2016-10-31. Its product type includes purchased reagents and consumables, self-produced reagents and consumables, as well as purchased equipment. The firm mainly operates its business in domestic markets, with Hubei, Hunan, Jiangsu, Henan and Shanghai province as its major markets.
Thalys Medical Technology Group, Inc. engages in the research, development, production, and sale of in vitro diagnostic products. The company is headquartered in Wuhan, Hubei and currently employs 1,637 full-time employees. The company went IPO on 2016-10-31. Its product type includes purchased reagents and consumables, self-produced reagents and consumables, as well as purchased equipment. The firm mainly operates its business in domestic markets, with Hubei, Hunan, Jiangsu, Henan and Shanghai province as its major markets.